Table 3 Clinico-pathological characteristics of the studies cases
N° | Sex/age | stage | Site of biopsy | Histologic variant | CD10 | Bcl-6 | Mum-1 | Bcl-2 | MIB-1 | subtype |
|---|---|---|---|---|---|---|---|---|---|---|
1 | F/60 | I | CNS, parietal | CBp | - | ++ | +++ | ++++ | 25% | Type 3 |
2 | M/40 | I | CNS, extradural | CBp, anaplastic cells | - | - | +++ | - | 50% | ABC |
3 | F/55 | I | CNS, frontal | CBp | - | ++ | ++++ | ++++ | 25% | Type 3 |
4 | F/45 | III | Nodal, axillary | T/HRTCL | - | - | +++ | ++++ | 90% | ABC |
5 | M/70 | III | Nodal, cervical | CBp | - | ++ | +++ | +++ | 25% | Type 3 |
6 | F/66 | III | Nodal, inguinal | CBp | - | - | +++ | ++++ | 75% | ABC |
7 | M/23 | II | Nodal, cervical | CB | +++ | ++ | - | - | 50% | GC |
8 | F/74 | I | Nodal, abdominal | CBp | +++ | ++ | - | - | 25% | GC |
9 | M/50 | I | Nodal, cervical | CB | - | ++ | - | - | 25% | GC |
10 | F/52 | III | Nodal, inguinal | CBp, anaplastic cells | - | +++ | +++ | +++ | 90% | Type 3 |
11 | M/43 | III | Nodal, inguinal | CBp | - | - | - | ++ | 90% | Type 3 |
12 | M/55 | IV | Nodal, abdominal | CBp, anaplastic cells | - | - | + | ++++ | 75% | ABC |
13* | M/34 | IV | Nodal, abdominal | CBp, anaplastic, clear cells | - | ++ | +++ | ++++ | 90% | Type 3 |
14 | M/48 | III | Nodal, cervical | CBp | - | +++ | ++ | ++++ | 75% | Type 3 |
15 | M/49 | I | Nodal, cervical | CB | ++ | - | - | - | 50% | GC |
16 | F/11 | II | Nodal, abdominal | CBp, clear cells | - | - | + | ++++ | 50% | ABC |
17 | F/9 | I | Nodal, cervical | CBp, anaplastic, clear cells | +++ | ++ | - | - | 10% | GC |
18 | M/37 | I | Nodal, cervical | CB p, anaplastic cells | +++ | +++ | - | - | 50% | GC |
19 | M/56 | III | Nodal, cervical | CBp, clear cells | - | - | +++ | ++ | 90% | ABC |
20 | F/63 | III | Nodal, abdominal | CBp, anaplastic cells | +++ | +++ | - | - | 50% | GC |
21 | M/31 | I | Extranodal, Appendicular | CBp | - | - | ++++ | - | 90% | ABC |
22 | M/15 | I | Extranodal, gastric | CBp | ++ | ++ | - | - | 90% | GC |
23 | F/49 | I | Extranodal, gastric | CB | - | - | - | - | 25% | Type 3 |
24 | M/70 | I | Extranodal, gastric | CBp | - | +++ | +++ | ++++ | 90% | Type 3 |
25 | M/35 | I | Extranodal, omentum | CBp | +++ | - | - | - | 10% | GC |
26 | M/52 | I | Extranodal, spleen | Histiocyte-like, anaplastic cells | - | ++ | - | - | 25% | GC |
27* | F/43 | I | Extranodal, retro-orbital | CBp | - | - | - | +++ | 90% | Type 3 |
28 | F/45 | I | Extranodal, scapular | CBp, spindle, clear cells | - | ++ | +++ | ++++ | 75% | Type 3 |
29 | F/46 | I | Extranodal, iliac bone | CBp, clear cells | +++ | ++ | - | - | 10% | GC |